Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • First Disclosures
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • First Disclosures
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

Article

  • Article
    Inhibition of Telomerase Activity in Human Cancer Cells by RNA Interference1
    Barbara A. Kosciolek, Kriton Kalantidis, Martin Tabler and Peter T. Rowley
    Mol Cancer Ther March 1 2003 2 (3) 209-216;

  • Article
    Efficacy of SCH66336, a Farnesyl Transferase Inhibitor, in Conjunction with Imatinib against BCR-ABL-positive Cells1
    Akihiro Nakajima, Tetsuzo Tauchi, Masahiko Sumi, W. Robert Bishop and Kazuma Ohyashiki
    Mol Cancer Ther March 1 2003 2 (3) 219-224;

  • Article
    Biological Activity of A-289099: An Orally Active Tubulin-binding Indolyloxazoline Derivative
    Stephen K. Tahir, Michael A. Nukkala, Nicolette A. Zielinski Mozny, R. Bruce Credo, Robert B. Warner, Qun Li, Keith W. Woods, Akiyo Claiborne, Stephen L. Gwaltney II, David J. Frost, Hing L. Sham, Saul H. Rosenberg and Shi-Chung Ng
    Mol Cancer Ther March 1 2003 2 (3) 227-233;

  • Article
    The Thioredoxin Redox Inhibitors 1-Methylpropyl 2-Imidazolyl Disulfide and Pleurotin Inhibit Hypoxia-induced Factor 1α and Vascular Endothelial Growth Factor Formation 1
    Sarah J. Welsh, Ryan R. Williams, Anne Birmingham, David J. Newman, D. Lynn Kirkpatrick and Garth Powis
    Mol Cancer Ther March 1 2003 2 (3) 235-243;

  • Article
    Interleukin-4 Receptor-targeted Cytotoxin Therapy of Androgen-dependent and -independent Prostate Carcinoma in Xenograft Models 1
    Syed R. Husain, Koji Kawakami, Mariko Kawakami and Raj K. Puri
    Mol Cancer Ther March 1 2003 2 (3) 245-254;

  • Article
    Z-FA-fmk Inhibits Effector Caspases but not Initiator Caspases 8 and 10, and Demonstrates That Novel Anticancer Retinoid-related Molecules Induce Apoptosis via the Intrinsic Pathway1
    Francisco J. Lopez-Hernandez, Maria A. Ortiz, Yolanda Bayon and F. Javier Piedrafita
    Mol Cancer Ther March 1 2003 2 (3) 255-263;

  • Article
    Celecoxib Acts in a Cyclooxygenase-2-independent Manner and in Synergy with Emodin to Suppress Rat Cholangiocarcinoma Growth in Vitro through a Mechanism Involving Enhanced Akt Inactivation and Increased Activation of Caspases-9 and -31
    Guan-Hua Lai, Zichen Zhang and Alphonse E. Sirica
    Mol Cancer Ther March 1 2003 2 (3) 265-271;

  • Article
    Protein Kinase C δ Is a Prosurvival Factor in Human Breast Tumor Cell Lines1
    Meredith A. McCracken, Loren J. Miraglia, Robert A. McKay and Jeannine S. Strobl
    Mol Cancer Ther March 1 2003 2 (3) 273-281;

  • Article
    Targeting Aurora2 Kinase in Oncogenesis: A Structural Bioinformatics Approach to Target Validation and Rational Drug Design1
    Hariprasad Vankayalapati, David J. Bearss, José W. Saldanha, Rubén M. Muñoz, Sangeeta Rojanala, Daniel D. Von Hoff and Daruka Mahadevan
    Mol Cancer Ther March 1 2003 2 (3) 283-294;

  • Article
    Functional Roles of Hyaluronan in B16-F10 Melanoma Growth and Experimental Metastasis in Mice1
    Mark E. Mummert, Diana I. Mummert, Lesa Ellinger and Akira Takashima
    Mol Cancer Ther March 1 2003 2 (3) 295-300;

  • Article
    Selection and Identification of Mimic Epitopes for Gastric Cancer-associated Antigen MG7 Ag1
    Li Xu, Bo-quan Jin and Dai-ming Fan
    Mol Cancer Ther March 1 2003 2 (3) 301-306;

  • Article
    Cloning and Functional Characterization of the Multidrug Resistance-associated Protein (MRP1/ABCC1) from the Cynomolgus Monkey
    Nathalie Godinot, Philip W. Iversen, Linda Tabas, Xiaoling Xia, Daniel C. Williams, Anne H. Dantzig and William L. Perry III
    Mol Cancer Ther March 1 2003 2 (3) 307-316;

  • Article
    Molecular Classification of Cancer: Unsupervised Self-Organizing Map Analysis of Gene Expression Microarray Data1
    David G. Covell, Anders Wallqvist, Alfred A. Rabow and Narmada Thanki
    Mol Cancer Ther March 1 2003 2 (3) 317-332;

Commentary

  • Commentary
    Harnessing the Power of RNA Interference to Advance Anticancer Drug Development
    Spyro Mousses
    Mol Cancer Ther March 1 2003 2 (3) 217-218;

  • Commentary
    Overcoming Resistance to Imatinib by Combining Targeted Agents 1
    Brian J. Druker
    Mol Cancer Ther March 1 2003 2 (3) 225-226;

  • Commentary
    Noninvasive Imaging of Anticancer Therapy
    Robert J. Gillies
    Mol Cancer Ther March 1 2003 2 (3) 333-334;

Minireview

  • Minireview
    Molecular Imaging and Cancer
    Ronald G. Blasberg
    Mol Cancer Ther March 1 2003 2 (3) 335-343;

Back to top
PreviousNext
Molecular Cancer Therapeutics: 2 (3)
March 2003
Volume 2, Issue 3
  • Table of Contents
  • About the Cover

Sign up for alerts

Issue Highlights

  • Molecular Classification of Cancer: Unsupervised Self-Organizing Map Analysis of Gene Expression Microarray Data1

Jump to

  • Article
  • Commentary
  • Minireview
Advertisement
  • Most Cited
  • Most Read
Loading
  • Anti-KIT DNA Aptamer Labeling in GIST
  • SLFN11 Expression in Prostate Cancer
  • Single-cell RNA-seq to Uncover Metastatic Targets in PDAC
  • Tipifarnib as a Precision Therapy for HRAS-Mutant HNSCC
  • ARX788 Efficacy in HER2-low and T-DM1–resistant Cancers
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement